Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

Abroad (travel likely)RecruitingPHASE3

Conditions

Mesial Temporal Lobe Epilepsy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic Arizona Epilepsy Center, Phoenix, Arizona, United States
Contact: Study coordinator (Kayla N Haeger, BSN, RN) · Haeger.Kayla@mayo.edu · 480-342-5075
Contact: Principal Investigator (Jonathon J Parker, MD, PhD)
Banner-University of Arizona Medical Center Tucson Comprehensive Epilepsy Program, Tucson, Arizona, United States
Contact: Study coordinator (Faten Sebaali, BA/MA) · fsebaali@arizona.edu · (520) 626-3576
Contact: Principal Investigator (David Labiner, MD)
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Contact: Study coordinator (Shellah Rogers, Nurse) · Scrogers2@uams.edu · 501-614-2086
Contact: Principal Investigator (Sisira Yadala, MD)
University of Southern California Keck Hospital, Los Angeles, California, United States
Contact: Study coordinator (Zoe B Durkin, SC) · zoe.durkin@med.usc.edu · 213-631-8487
Contact: Principal Investigator (Charles Y Liu, MD, PhD)
University of California Los Angeles, Los Angeles, California, United States
Contact: Study coordinator (Elizabeth Cruz) · ElizabethCruz@mednet.ucla.edu · 310-825-6930
Contact: Principal Investigator (John M Stern, MD)
UC Irvine Medical Center, Orange, California, United States
Contact: Study coordinator (UCI Alpha Clinic) · alphaclinic@hs.uci.edu · 949-824-3990
Contact: Principal Investigator (Mona Sazgar, MD)
Stanford University, Palo Alto, California, United States
Contact: Study coordinator (Jordan Seliger, CRC, MA) · jseliger@stanford.edu · 650-460-9260
Contact: Principal Investigator (Kevin Graber, MD)
University of California Davis, Sacramento, California, United States
Contact: Study coordinator (Evan Y Shen, BA) · evshen@ucdavis.edu · 916-734-3009
Contact: Principal Investigator (Jack J Lin, MD)
University of California San Diego, San Diego, California, United States
Contact: Study coordinator (Mateo Santizo) · msantizo@health.ucsd.edu · 858-583-0929
Contact: Principal Investigator (Jerry J Shih, MD)
University of California San Francisco, San Francisco, California, United States
Contact: Study coordinator (Sydnie Beausoleil) · Sydnie.Beausoleil@ucsf.edu · 631-428-9688
Contact: Principal Investigator (Robert C Knowlton, MD)
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Contact: Study coordinator (Trey Jouard, MS) · Trey.Jouard@cuanschutz.edu · 970-817-4272
Contact: Principal Investigator (Lesley Kaye, MD)
George Washington University, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Preethy Feit, SC) · pfeit@mfa.gwu.edu · 202-677-6765
Contact: Principal Investigator (Mohamad Koubeissi, MD)
University of Miami, Miami, Florida, United States
Contact: Study coordinator (Letitia Fisher) · lfisher@miami.edu · 305-775-8582
Contact: Principal Investigator (Jonathan R. Jagid, MD)
Rush University Medical Center, Chicago, Illinois, United States
Contact: Study coordinator (Amanda Sremac, BS) · Amanda_C_Sremac@rush.edu · 312-942-0539
Contact: Principal Investigator (Rebecca O'Dwyer, MD)
University of Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Agnieszka Stadnik, MS) · astadnik@bsd.uchicago.edu · 773-702-8996
Contact: Principal Investigator (Peter Warnke, MD)
University of Iowa Health Care, Iowa City, Iowa, United States
Contact: Study coordinator (Loraine Brenner, MSN) · loraine-brenner@uiowa.edu · 319-356-4361
Contact: Principal Investigator (Mark Granner, MD)
Ochsner Clinic Foundation, New Orleans, Louisiana, United States
Contact: Study coordinator (Neydin Osorio, BS, CRC) · neydin.tejeda@ochsner.org · 504-703-5577
Contact: Principal Investigator (Fawad Khan, MD)
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Contact: Study coordinator (Anna George, MSc) · ageorge5@bidmc.harvard.edu · 617-632-7031
Contact: Principal Investigator (Joshua P Aronson, MD)
Wayne State University/Detroit Medical Center Comprehensive Epilepsy Program, Detroit, Michigan, United States
Contact: Study coordinator (Kelly X Jia, MD) · xjia@med.wayne.edu · 313-966-9407
Contact: Principal Investigator (Maysaa Basha, MD)
Dartmouth Hitchcock Medical Center/ Department of Neurology, Lebanon, New Hampshire, United States
Contact: Study coordinator (Anastasia Kanishcheva, PM) · anastasia.kanishcheva@hitchcock.org · 603) 650-0260
Contact: Principal Investigator (Krzysztof A, Bujarski, MD)
Hofstra Northwell Comprehensive Epilepsy Center, Great Neck, New York, United States
Contact: Study coordinator (Isabella Henderson) · IHenderson@northwell.edu · 212-434-4837
Contact: Principal Investigator (Sean Hwang, MD)
NYU Langone Comprehensive Epilepsy Center, New York, New York, United States
Contact: Study coordinator (Jack C Carter, BS) · jack.carter@nyulangone.org · 646-558-0841
Contact: Principal Investigator (Orrin Devinsky, MD)
SUNY Upstate Medical University, Syracuse, New York, United States
Contact: Study coordinator (Lena F Deb, BA) · debl@upstate.edu · 315-464-9756
Contact: Principal Investigator (Robert L Beach, MD, PhD)
Atrium Health, Charlotte, North Carolina, United States
Contact: Study coordinator (Dianelis Diaz, RN, BSN, CRC) · dianelis.diaz@atriumhealth.org · 704-446-1349
Contact: Principal Investigator (Rajdeep Singh, MD)
Duke University Hospital, Durham, North Carolina, United States
Contact: Study coordinator (Hazani Benitez-Rosas) · Hazani.benitez-rosas@duke.edu · 919-681-4974
Contact: Principal Investigator (Derek Southwell, MD, PhD)
Atrium Wake Forest Baptist, Winston-Salem, North Carolina, United States
Contact: Study coordinator (Carolyn W Hedrick, RMA, CCRP) · cwhedric@wakehealth.edu · 336-716-8694
Contact: Principal Investigator (Gautam S Popli, MBBS, MBA)
Oregon Health and Science University, Portland, Oregon, United States
Contact: Study coordinator (Claire Dorfman, BA) · dorfman@ohsu.edu · 971-413-9201
Contact: Principal Investigator (David C Spencer, MD)
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Latasha Adams, MBS) · Latasha.adams2@jefferson.edu · 215-955-2606
Contact: Principal Investigator (Michael Sperling, MD)
UT Southwestern Medical Center, Dallas, Texas, United States
Contact: Study coordinator (Vamsi Vemireddy, SC) · vamsidhara.vemireddy@utsouthwestern.edu · 214-645-8159
Contact: Principal Investigator (Sasha Alick-Lindstrom, MD)
UTHealth Houston, Houston, Texas, United States
Contact: Study coordinator (Eliana M Klier, PhD) · Eliana.Klier@uth.tmc.edu · 713-500-5442
Contact: Principal Investigator (Nitin Tandon, MD)
University of Utah Health, Salt Lake City, Utah, United States
Contact: Study coordinator (Laura Beeler, BS) · laura.beeler@hsc.utah.edu · 928-530-7990
Contact: Principal Investigator (Amir Arain, MD)
University of Washington Regional Epilepsy Center, Seattle, Washington, United States
Contact: Study coordinator (Jennifer Steele, CRC) · recresearch@uw.edu · 206-744-2336
Contact: Principal Investigator (Shahin Hakimian, MD, PhD)
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Study coordinator (Sarah Young, MS) · scyoung@mcw.edu · 414-955-0989
Contact: Principal Investigator (Sean Lew, MD)

Study leads

Eduardo Dunayevich, MD
Study Director
Neurona Therapeutics

View source on ClinicalTrials.gov Contact study team (email)